Cargando…
CDK4, a new metabolic sensor that antagonizes AMPK
Cyclin-dependent kinase 4 (CDK4) is a positive regulator of cell cycle progression, however, there is growing evidence demonstrating that its function exceeds the control of cell division. Here we show that CDK4 is an important regulator of cellular substrate utilization through direct inhibition of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154832/ https://www.ncbi.nlm.nih.gov/pubmed/30263936 http://dx.doi.org/10.1080/23723556.2017.1409862 |
_version_ | 1783357771036491776 |
---|---|
author | Fajas, L. Lopez-Mejia, I. C. |
author_facet | Fajas, L. Lopez-Mejia, I. C. |
author_sort | Fajas, L. |
collection | PubMed |
description | Cyclin-dependent kinase 4 (CDK4) is a positive regulator of cell cycle progression, however, there is growing evidence demonstrating that its function exceeds the control of cell division. Here we show that CDK4 is an important regulator of cellular substrate utilization through direct inhibition of the metabolic regulator AMPK (AMP-activated protein kinase). |
format | Online Article Text |
id | pubmed-6154832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-61548322019-05-16 CDK4, a new metabolic sensor that antagonizes AMPK Fajas, L. Lopez-Mejia, I. C. Mol Cell Oncol Commentary Cyclin-dependent kinase 4 (CDK4) is a positive regulator of cell cycle progression, however, there is growing evidence demonstrating that its function exceeds the control of cell division. Here we show that CDK4 is an important regulator of cellular substrate utilization through direct inhibition of the metabolic regulator AMPK (AMP-activated protein kinase). Taylor & Francis 2018-05-16 /pmc/articles/PMC6154832/ /pubmed/30263936 http://dx.doi.org/10.1080/23723556.2017.1409862 Text en © 2018 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Commentary Fajas, L. Lopez-Mejia, I. C. CDK4, a new metabolic sensor that antagonizes AMPK |
title | CDK4, a new metabolic sensor that antagonizes AMPK |
title_full | CDK4, a new metabolic sensor that antagonizes AMPK |
title_fullStr | CDK4, a new metabolic sensor that antagonizes AMPK |
title_full_unstemmed | CDK4, a new metabolic sensor that antagonizes AMPK |
title_short | CDK4, a new metabolic sensor that antagonizes AMPK |
title_sort | cdk4, a new metabolic sensor that antagonizes ampk |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154832/ https://www.ncbi.nlm.nih.gov/pubmed/30263936 http://dx.doi.org/10.1080/23723556.2017.1409862 |
work_keys_str_mv | AT fajasl cdk4anewmetabolicsensorthatantagonizesampk AT lopezmejiaic cdk4anewmetabolicsensorthatantagonizesampk |